Baker Bros. Advisors LP Entrada Therapeutics, Inc. Put Options Transaction History
Baker Bros. Advisors LP
- $9.86 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TRDA
# of Institutions
107Shares Held
28.8MCall Options Held
15.7KPut Options Held
0-
Mpm Asset Management LLC Cambridge, MA4.38MShares$23.1 Million67.92% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.31MShares$22.7 Million19.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$8.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$8.47 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $166M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...